Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19156700 | 0.95 | CYP1A2 (0.31) | CYP1A2CYP2A6 | |
| SCHEMBL18101516 | 0.92 | HPGD (0.33) | CYP1A2CYP2A6ALDH1A1KDM4EGAA | |
| SCHEMBL18101524 | 0.92 | KDM4E (0.35) | CYP1A2ALDH1A1KDM4EGAAHPGD | |
| SCHEMBL18101507 | 0.91 | LMNA (0.33) | CYP1A2CYP2A6ALDH1A1KDM4EGAA | |
| SCHEMBL18101555 | 0.91 | NPC1 (0.30) | MAPTNPC1POLB | |
| SCHEMBL18101585 | 0.91 | LMNA (0.30) | LMNA | |
| SCHEMBL18101520 | 0.90 | ALOX5 (0.32) | GAAMAOBALOX5 | |
| SCHEMBL18103988 | 0.89 | — | — | |
| SCHEMBL17676445 | 0.89 | HPGD (0.33) | CYP1A2CYP2A6ALDH1A1KDM4EGAA | |
| SCHEMBL18101508 | 0.88 | TDP1 (0.35) | CYP1A2CYP2A6ALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | EPB41, RPS4X, OR10J3 | CYP1A2 1746/4885CYP2A6 2649/4885ALDH1A1 695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.